why wouldn’t you want your child vaccinated?
some of the barriers to increasing the rates of hpv vaccination include parental concerns about their child’s sexuality, limited awareness of hpv and the link to cancer, and worry over vaccine safety — something that the covid-19 pandemic has amplified.
“people have a lot of uncertainty, especially now with covid and the concern that vaccines don’t work,” says
dr. cathy popadiuk, chair of the
canadian foundation for women’s health, canada’s national not-for-profit fundraising foundation for women’s sexual and reproductive health. “vaccines work for antibodies and for other parts of the immune system, like t cells and other things that we don’t measure.”
she adds that the hpv vaccine is a good example of how well vaccinations work.
“if you got vaccinated in 2007, it’s still working,” she says. “that should be very reassuring to the population that vaccinations also have longer-term benefits.”
popadiuk has been a practicing gynecologic oncologist in newfoundland since 1998 and teaches in the faculty of medicine at memorial university. she has a special interest in cervical cancer and is also working with the national microbiology lab in winnipeg to study hpv incidence in young women.
the timing, she says, is right. it’s been 15 years since the hpv vaccines came into play and she’s excited about the results of immunization coming to light, both in research and in the results she is seeing in her own patients.
‘you can actually see less cancer happening’
popadiuk says the first abnormality the vaccine helped to address was low-grade warts. then, as the vaccinated cohort matured through high school and sexual activity, there were fewer high-grade lesions found.
“pre-cancerous cells can usually become cancer in 10 or more years, and we’ve been seeing less high-grade abnormalities among younger women who have been in that vaccinated cohort,” she says. “that’s really exciting. you can actually see less cancer happening in 25 to 29-year-olds.”